Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-25 @ 5:01 AM
NCT ID:
NCT00357318
Brief Title:
Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
Official Title:
A Phase I Study of Bevacizumab in Combination With SU11248
Study:
NCT00357318
Protocol Section:
NCT00357318